Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v2-FR
Language English French
Date Updated 2023-06-16 2023-05-19
Drug Identification Number 02193221 02193221
Brand name THIAMIJECT INJECTION - LIQ IM IV 100MG/ML THIAMIJECT INJECTION - LIQ IM IV 100MG/ML
Common or Proper name THIAMINE HYDROCHLORIDE INJECTION 100MG/ML THIAMINE HYDROCHLORIDE INJECTION 100MG/ML
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients THIAMINE HYDROCHLORIDE THIAMINE HYDROCHLORIDE
Strength(s) 100MG 100MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5 x 10mL vial / fiole 5 x 10mL vial / fiole
ATC code A11DA A11DA
ATC description VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12 VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2023-06-02
Actual start date 2023-05-26
Estimated end date 2023-06-15
Actual end date 2023-06-15
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments